Peanut Allergen Powder (Palforzia)

Date: March 9, 2020
Issue #: 
1593Summary: 
The FDA has approved peanut allergen powder-dnfp
(Palforzia– Aimmune) for use as oral immunotherapy
to mitigate allergic reactions, including anaphylaxis,
caused by accidental peanut exposure in patients with
a confirmed peanut allergy. It is the first drug to be
approved in the US for this indication; Viaskin Peanut,
an immunotherapy patch, is under FDA review for the
same indication.

Source: The Medical Letter - February 4, 2020 Category: Drugs & Pharmacology Authors: admin Tags: Allergies Anaphylaxis Epinephrine Immunotherapy Palforzia peanut allergen powder Viaskin Peanut Source Type: research